Company Analysis

Curis, Inc. (CRIS)

Nasdaq: CRIS · Biological Products, (No Diagnostic Substances) · Lexington, MA · filing with the SEC since 2000
Grade4.1
◀ Past 3.4● Present 4.1▶ Future 4.5
1 est.

The grade of Curis, Inc.

Nine metrics read from its own filings, by tense
Headline grade
4.1/10
◀ Past3.425% of the headline
● Present4.135% of the headline
▶ Future4.540% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

3.4/1025% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed
3.0/10

Has it survived what it has been through?

13 warning events since 2017; the latest 2026-11-06.

weight 22% of this tense · 30th percentile among 159 sector filers · read for itself

From the record

Curis, Inc.'s filings since 2017 show 13 warning events: a notice about its exchange listing (8-K item 3.01, 13 times, the latest 2026-11-06) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
3.8/10

What has it actually done, year after year?

-0.6% a year over 9 filed years; profitable in 0 of 9.

weight 45% of this tense · 38th percentile among 102 sector filers · read for its customers

From the record

Curis, Inc.'s 9 filed years say what it did: revenue went from $10 million in fiscal 2017 to $9 million in fiscal 2025, down 0.6% a year; it rose in 3 of 8 years; the deepest fall was 13% from fiscal 2024 to fiscal 2025; net income was positive in 0 of 9 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span-0.6%bottom 25% of its family
  • the share of years revenue rosebottom 21% of its family
  • the share of filed years with a profitbottom 31% of its family
  • the deepest fall from a revenue peak13.4%top 25% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate
3.3/10

How has it treated the people who own it?

SI estimate 3.3/10, confidence 35 of 100 (one part).

weight 33% of this tense · 33rd percentile among 146 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, the share count over the years, which ranks in the bottom 33% of 146 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read
Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned
one part: the share count over the years, the one part on file, ranked among 146 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Curis, Inc.'s shareholder treatment is put at 3.3 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 33% of 146 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

4.1/1035% of the headline grade · 3 of 3 filed

Financial health

as filed
2.3/10

Is it financially healthy right now?

ROE -139%: lost 139¢ per shareholder dollar. Leverage 73%: owes 73¢ per asset dollar.

weight 45% of this tense · 23rd percentile among 147 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Curis, Inc. lost about 139 cents for every dollar of shareholders' money. Leverage: it owed about 73 cents per dollar of assets, and net share issuance: its share count grew 108.7% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetsbottom 28% of its family
  • return on equitybottom 23% of its family
  • the share count against the year beforebottom 17% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
4.6/10

How strong is its position in its industry?

bottom 46% of 102 in its family; net margin -80.3%.

weight 22% of this tense · 46th percentile among 102 sector filers · read for its customers

From the record

Curis, Inc.'s standing among 102 graded names in its industry family: revenue of $9 million in fiscal 2025 ranks in the bottom 36% by size; a net margin of -80.3% ranks in the top 34%; revenue growth of -2.4% a year over the last 3 filed years ranks in the bottom 36% (its annual reports).

What it rests on

  • revenue against the family$9.4Mbottom 36% of its family
  • net margin-80.3%top 34% of its family
  • three-year revenue growth-2.4%bottom 36% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

as filed
6.3/10

What are the people in charge doing?

top 37% of 110 in its family for leadership; chief executive since 2018.

weight 33% of this tense · 63rd percentile among 110 sector filers · read for its shareholders

From the record

Curis, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Dentzer, James E (President & CEO, as filed), filing under that title since 2018-09-27, 8.1 years (top 18% of its family); the 9 officers and directors filing in the last fifteen months have been on the record a median of 4.9 years (bottom 35%); 3 officer or director changes were reported on Form 8-K since 2023-11-13, against the 9 people in charge now (top 30%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

What it rests on

  • officer and director changes on Form 8-K, against the people in charge3 in three years among 9 peopletop 30% of its family
  • the median years the people in charge have filed4.9 yearsbottom 35% of its family
  • the chief executive's years on the record8.1 yearstop 18% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

▶ Future

What are they set up to do next?

4.5/1040% of the headline grade · 3 of 3 filed

Room to expand

as filed
5.2/10

How much room does it have to grow?

top 48% of 92 in its family for room to expand.

weight 33% of this tense · 52nd percentile among 92 sector filers · read for itself

From the record

Curis, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $5 million against no long-term debt tagged leaves 25.3% of its assets as net cash, bottom 48% of its family; cash from operations less capital spending is -288.1% of revenue (bottom 45%); research spending of 299.2% of revenue (top 38%) (its annual report).

What it rests on

  • cash less debt against assets25.3%bottom 48% of its family
  • cash from operations less capital spending against revenue-288.1%bottom 45% of its family
  • research spending against revenue299.2%top 38% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
3.4/10

What could actually drive growth from here?

bottom 33% of 100 in its family for growth drivers.

weight 45% of this tense · 33rd percentile among 100 sector filers · read for its customers

From the record

Curis, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -2.4% a year over the last three filed years against -0.6% over all 9, slowing (top 47% of its family); the newest year grew -13.4% (bottom 25%); research spending grew -13.2% a year (bottom 23%) (its annual reports). Curis, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

What it rests on

  • three-year growth against the whole span-1.8 points a yeartop 47% of its family
  • the newest year's revenue growth-13.4%bottom 25% of its family
  • three-year growth of research spending-13.2%bottom 23% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
6.0/10

Did its newest year beat what its own record pointed to?

top 40% of 72 in its family for expectations against reality.

weight 22% of this tense · 60th percentile among 72 sector filers · read for its shareholders

From the record

Curis, Inc.'s newest year against its own record: revenue of $9 million in fiscal 2025 came in 16.4% below the $11 million its prior three years' pace pointed to (bottom 29% of its family); net income of $8 million against a prior three-year average of $49 million (top 19%); a net margin of -80.3% against losses larger than its revenue before (top 30%) (its annual reports).

What it rests on

  • revenue against the prior three years' pace-16.4%bottom 29% of its family
  • net income against the prior three years' average+85%top 19% of its family
  • net margin against its prior averageup more than 100 pointstop 30% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton CRIS · research, not advice